Announcement-stage whole-body ultrasound scanner. The ultrasound imaging substrate is real; the broad whole-body-screening / mortality-reduction claim is unvalidated and not FDA-cleared to diagnose. Mirrors the AngioCode pattern — real substrate, broad interpretation unvalidated.
Midjourney Medical's full-body ultrasound scanner is an announcement-stage device: a whole-body ultrasound tomography system, described in June 2026 coverage, that claims to build a 3D body map at near-MRI detail in about sixty seconds. It belongs to the Sensing Physics family, because ultrasound imaging is real, established physics. The atlas places it under study — the imaging substrate is real, but the broad whole-body-screening claim is unvalidated and the device is not cleared to diagnose.
The half to keep is genuine: whole-body ultrasound imaging is legitimate physics. The described approach — ultrasound tomography using on the order of 500,000 transducer micro-elements with water immersion to produce a 3D body map — is built on a real, well-understood imaging modality, and the announced partnership is with an established ultrasound maker (Butterfly Network). Ultrasound as a sensing method is not in question. That is the substrate the entry credits: a real imaging physics, capable of producing real images.
This is the core, and the distinction is between a real method and an unproven program built on it. The imaging substrate is real; the claims around it — near-MRI detail, roughly 100× faster and 10× cheaper, a whole-body screen in about sixty seconds, and the headline that such screening could “prevent up to 30% of deaths” — are unvalidated. That earns grade D: announcement-stage (2026-06), where the evidence is press coverage rather than peer-reviewed data, and accuracy and independent validation are both open. The record carries no sources for this entry, and accordingly none is cited here; per the record this is announcement-stage and press-only, with independent validation, accuracy, and regulatory status all pending re-check before publication. No peer-reviewed study, accuracy figure, or trial is asserted here, because none exists in the record — that absence is exactly what grade D records.
Keep the axes apart. Plausibility for the method is high (ultrasound imaging is real); the grade for the broad screening claim is only D; and the tier follows the claim, not the physics. The entry's flag states this directly: “announcement-stage — independent validation / accuracy / regulatory status all OPEN.” A plausible imaging method does not make a whole-body-mortality claim true, and a press announcement is not evidence. The flag is the honest center of gravity here: almost everything that would let the broad claim be assessed is, at this writing, simply not yet available.
The single most important regulatory fact is explicit in the record: per the coverage, the device is NOT cleared to diagnose. EU MDR, Russia, China NMPA, and Australia TGA status are all “not found.” The positioning is consumer / wellness — a prototype scanner with a planned “Midjourney Spa” in San Francisco for 2027 — not a cleared diagnostic. This is the atlas's standing rule in its sharpest form: a clearance is a market-access fact for a specific indication, and here there is no diagnostic clearance to point to at all. An announcement, a partnership, and a planned spa are not regulatory authorization and are not efficacy.
The origin on record is recent: Midjourney — an AI-image company — announced the scanner in June 2026, in partnership with Butterfly Network, with the San Francisco “Midjourney Spa” planned for 2027. Its natural pair in the atlas is AngioCode: the record explicitly says this entry “mirrors the AngioCode pattern — real substrate, broad interpretation unvalidated.” Both are real sensors carrying interpretations wider than their validation. For how a legitimate measurement gets stretched into a broad diagnostic promise, see the lineage page and the other Sensing Physics entries.
Keep: whole-body ultrasound imaging as real, legitimate physics — a genuine sensing substrate. Set aside: the unvalidated whole-body-screening and “prevent up to 30% of deaths” claims, which are announcement-stage (grade D), press-only, and attached to a device that is not cleared to diagnose. The site copy keeps Midjourney's own “AI / ultrasound / spa” framing without embellishment. The scanner may image; whether it screens, and whether the broad claim holds, is open and unverified.
Registration or clearance is a market-access fact, never proof of efficacy.
| US — FDA | NOT cleared to diagnose (per coverage). |
|---|---|
| EU — MDR | Not found. |
| Russia | Not found. |
| China — NMPA | Not found. |
| Australia — TGA | Not found. |
No verified primary source available — claims carried as unverified; not fabricated.
Announcement-stage (2026-06); sources are press coverage only, not peer-reviewed — re-check validation / accuracy / regulatory status before publish.